DIPLOMAT PHARMACY, INC.
DPLO
DPLO was delisted on the 7th of February, 2020.
1 hedge funds and large institutions have $1K invested in DIPLOMAT PHARMACY, INC. in 2020 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 134 closing their positions.
99% less funds holding
Funds holding: 138 → 1 (-137)
100% less capital invested
Capital invested by funds: $227M → $1K (-$227M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 134
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$37.5M |
| 2 |
SI
Stephens Inc
Little Rock,
Arkansas
|
-$30.5M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$29.3M |
| 4 |
Renaissance Technologies
New York
|
-$10.2M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$9.83M |
DPLO Hedge Fund Activity: Q1 2020 in Review
1 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in DIPLOMAT PHARMACY, INC. (DPLO) for Q1 2020, worth a combined $1K — down 100% from $227M a quarter earlier.
Sellers outnumbered buyers: 134 funds closed out of DPLO and 0 opened new positions — a net loss of 134 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was BlackRock, exiting entirely with an estimated $37.5M sold.
- 1 institutional investor held DIPLOMAT PHARMACY, INC. (DPLO) as of Q1 2020, down from 138 in Q4 2019.
- Funds reported $1K of DIPLOMAT PHARMACY, INC. stock for Q1 2020, down 100% quarter-over-quarter.
- 0 funds opened new DIPLOMAT PHARMACY, INC. positions in Q1 2020 and 134 closed out, a net change of -134 holders.
- The largest DIPLOMAT PHARMACY, INC. seller in Q1 2020 was BlackRock, an estimated $37.5M sold.
Based on aggregated 13F filings for Q1 2020.